Organon & Co. (NYSE: OGN) leader sells 14,761 shares at $13.57

Rhea-AI Filing Summary

Organon & Co. executive Juliana Papa Drinane, Head of Mfg & Supply, reported selling 14,761 shares of common stock on 2026-08-05 at $13.57 per share in an open-market or private transaction. Following the sale, she directly holds 18,474.703 shares of Organon common stock.

Insider Trade Summary

Net Seller: 14,761 shares

Net Sell 1 txn

Insider Drinane Juliana Papa

Role Head of Mfg & Supply

Sold 14,761 shs ($200K)

Type	Security	Shares	Price	Value
Sale	Common Stock	14,761	$13.57	$200K

Holdings After Transaction: Common Stock — 18,474.703 shares (Direct)

Key Figures

Shares sold: 14,761 shares Sale price: $13.57 per share Shares owned after sale: 18,474.703 shares

3 metrics

Shares sold 14,761 shares Common Stock sale on 2026-08-05

Sale price $13.57 per share Price for the 14,761-share Common Stock sale

Shares owned after sale 18,474.703 shares Directly owned Common Stock following the transaction

Key Terms

Common Stock, open market or private transaction, direct ownership

3 terms

Common Stock financial

"Security title reported as Common Stock in the transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open market or private transaction financial

"Transaction code description: Sale in open market or private transaction"

direct ownership financial

"Ownership type is listed as direct for the reported shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 04:05 PM Accepted by SEC EDGAR 08/05/2026 - 04:04 PM Learn about SEC filing dates

FAQ

What insider transaction did Organon (OGN) disclose in this Form 4?

Organon & Co. disclosed that executive Juliana Papa Drinane sold 14,761 shares of its common stock. The transaction occurred on 2026-08-05 and was reported as a sale in an open-market or private transaction at a stated per-share price.

At what price were the Organon (OGN) shares sold by Juliana Papa Drinane?

Juliana Papa Drinane sold the Organon common shares at $13.57 per share. This price applies to the reported sale of 14,761 shares of common stock on 2026-08-05, characterized as an open-market or private transaction.

How many Organon (OGN) shares did Juliana Papa Drinane sell in this transaction?

She sold 14,761 shares of Organon common stock. The sale was reported as a non-derivative transaction in common stock, executed on 2026-08-05 at a price of $13.57 per share, and reduced her directly held position.

How many Organon (OGN) shares does Juliana Papa Drinane hold after the sale?

After the reported sale, Juliana Papa Drinane directly holds 18,474.703 Organon common shares. This post-transaction holding reflects her remaining direct ownership following the disposition of 14,761 shares in the 2026-08-05 transaction.

What is Juliana Papa Drinane’s role at Organon (OGN) related to this insider trade?

Juliana Papa Drinane is identified as Organon’s Head of Mfg & Supply. Her reported sale of 14,761 common shares on 2026-08-05 reflects trading activity by a senior officer with direct ownership of Organon stock both before and after the transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Drinane Juliana Papa

(Last) (First) (Middle)

C/O ORGANON &CO.

30 HUDSON STREET, FLOOR 33

(Street)

JERSEY CITY NEW JERSEY 07302

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head of Mfg & Supply

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		S		14,761	D	$13.57	18,474.703	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)